ReviewFrontiers in molecular biosciences2026
Glycocalyx at the host-virus interface: a double-edged sword in virus infection and tissue damage.
Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Viral entry is traditionally viewed as a receptor-mediated event, yet this paradigm overlooks the glycocalyx (GLX) - a dynamic, multifunctional layer of glycans, proteoglycans, and glycolipids that forms the host's first molecular interface with pathogens. Emerging evidence positions the GLX as a bidirectional regulator of infection, capable of both restricting viral access and orchestrating virion capture, receptor clustering, and entry pathway selection. In herpes simplex virus (HSV) infection, cell-type specific GLX architectures on epithelial, endothelial, and immune cells dictate viral tropism, migration, antigen sensing, and immune synapse formation. Infection and inflammation remodel or shed the GLX, perturbing receptor organization, signaling networks, and immune function, thereby contributing to tissue pathology. Beyond its barrier role, the GLX acts as a mechanochemical sensor, integrating environmental cues to coordinate tissue homeostasis and repair. Here, we synthesize recent advances elucidating how GLX composition, spatial organization, and mechanical properties shape viral entry and host responses. We further highlight emerging biomimetic and synthetic strategies to manipulate the GLX, offering new avenues to interrogate virus-host interactions and therapeutic intervention. Collectively, these perspectives redefine the GLX as a central regulator of herpesvirus pathogenesis, functioning simultaneously as a protective shield and facilitator of infection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.